CohBar (NASDAQ:CWBR) Stock Price Up 12.5%

CohBar, Inc. (NASDAQ:CWBR)’s stock price rose 12.5% during trading on Wednesday . The company traded as high as $0.90 and last traded at $0.90. Approximately 356 shares changed hands during mid-day trading, a decline of 89% from the average daily volume of 3,366 shares. The stock had previously closed at $0.80.

CohBar Price Performance

The firm has a market cap of $2.62 million, a PE ratio of -0.21 and a beta of 1.54. The stock has a 50-day moving average price of $0.82 and a 200 day moving average price of $1.08.

Institutional Investors Weigh In On CohBar

Hedge funds and other institutional investors have recently made changes to their positions in the business. RVW Wealth LLC purchased a new stake in CohBar during the fourth quarter valued at about $4,029,000. Vanguard Group Inc. grew its position in CohBar by 88.5% during the third quarter. Vanguard Group Inc. now owns 33,293 shares of the company’s stock valued at $103,000 after acquiring an additional 15,628 shares during the period. Finally, Millennium Management LLC grew its position in CohBar by 241.1% during the second quarter. Millennium Management LLC now owns 208,603 shares of the company’s stock valued at $40,000 after acquiring an additional 147,442 shares during the period. Hedge funds and other institutional investors own 2.47% of the company’s stock.

About CohBar

CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.